Detalhe da pesquisa
1.
A new MVA ancestor-derived oncolytic vaccinia virus induces immunogenic tumor cell death and robust antitumor immune responses.
Mol Ther
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38734899
2.
SARS-CoV-2 inactivation in laboratory animal tissues with 4% formaldehyde or 5% glutaraldehyde for transfer to biosafety level 1 laboratories.
Vet Pathol
; 61(2): 201-206, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698272
3.
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
Proc Natl Acad Sci U S A
; 118(28)2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34162739
4.
MERS-CoVâSpecific T-Cell Responses in Camels after Single MVA-MERS-S Vaccination.
Emerg Infect Dis
; 29(6): 1236-1239, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37209676
5.
Mouse models in COVID-19 research: analyzing the adaptive immune response.
Med Microbiol Immunol
; 212(2): 165-183, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35661253
6.
Prolonged SARS-CoV-2 RNA Shedding from Therapy Cat after Cluster Outbreak in Retirement Home.
Emerg Infect Dis
; 27(7): 1974-1976, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34152973
7.
Immunogenic cell death of dendritic cells following modified vaccinia virus Ankara infection enhances CD8+ T cell proliferation.
Eur J Immunol
; 48(12): 2042-2054, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30259962
8.
Editorial on special issue on "Immunobiology of Viral Infections".
Med Microbiol Immunol
; 212(2): 123-124, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36991263
9.
Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S.
Biologicals
; 54: 58-62, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29759890
10.
Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
J Virol
; 90(22): 10209-10219, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27581985
11.
Myristoylation increases the CD8+T-cell response to a GFP prototype antigen delivered by modified vaccinia virus Ankara.
J Gen Virol
; 97(4): 934-940, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26864442
12.
Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein.
J Virol
; 89(16): 8651-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26018172
13.
Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.
J Virol
; 88(18): 10946-57, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25008931
14.
Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies.
J Virol
; 87(21): 11950-4, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23986586
15.
Critical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpox.
PLoS Pathog
; 8(3): e1002557, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22396645
16.
Protective MVA-ST Vaccination Robustly Activates T Cells and Antibodies in an Aged-Hamster Model for COVID-19.
Vaccines (Basel)
; 12(1)2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38250865
17.
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection.
Viruses
; 16(3)2024 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38543782
18.
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans.
NPJ Vaccines
; 9(1): 20, 2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278816
19.
Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice.
Viruses
; 15(5)2023 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243266
20.
The effect of Toll-like receptor agonists on the immunogenicity of MVA-SARS-2-S vaccine after intranasal administration in mice.
Front Cell Infect Microbiol
; 13: 1259822, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37854858